Randall O. Winston

Array ( [id] => 3706163 [patent_doc_number] => 05654279 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Tissue destruction in cryosurgery by use of thermal hysteresis' [patent_app_type] => 1 [patent_app_number] => 8/625074 [patent_app_country] => US [patent_app_date] => 1996-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5682 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654279.pdf [firstpage_image] =>[orig_patent_app_number] => 625074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621156 [patent_doc_number] => 05641745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Controlled release biodegradable micro- and nanospheres containing cyclosporin' [patent_app_type] => 1 [patent_app_number] => 8/479509 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2711 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641745.pdf [firstpage_image] =>[orig_patent_app_number] => 479509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636077 [patent_doc_number] => 05631347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Reducing gelation of a fatty acid-acylated protein' [patent_app_type] => 1 [patent_app_number] => 8/484545 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4540 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631347.pdf [firstpage_image] =>[orig_patent_app_number] => 484545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661613 [patent_doc_number] => 05624902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Peptide inhibitors of calmodulin' [patent_app_type] => 1 [patent_app_number] => 8/485396 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5865 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624902.pdf [firstpage_image] =>[orig_patent_app_number] => 485396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771099 [patent_doc_number] => 05756458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Stabilized potent GRF analogs' [patent_app_type] => 1 [patent_app_number] => 8/442029 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13828 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756458.pdf [firstpage_image] =>[orig_patent_app_number] => 442029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625033 [patent_doc_number] => 05602230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Peptide inhibitors of selectin binding' [patent_app_type] => 1 [patent_app_number] => 8/438475 [patent_app_country] => US [patent_app_date] => 1995-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10552 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602230.pdf [firstpage_image] =>[orig_patent_app_number] => 438475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688696 [patent_doc_number] => 05663291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Process for obtaining insulin having correctly linked cystine bridges' [patent_app_type] => 1 [patent_app_number] => 8/389487 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5970 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663291.pdf [firstpage_image] =>[orig_patent_app_number] => 389487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3701533 [patent_doc_number] => 05653974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Preparation and characterization of liposomal formulations of tumor necrosis factor' [patent_app_type] => 1 [patent_app_number] => 8/351002 [patent_app_country] => US [patent_app_date] => 1994-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 17002 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/653/05653974.pdf [firstpage_image] =>[orig_patent_app_number] => 351002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728779 [patent_doc_number] => 05652214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Treating disorders by application of insulin-like growth factors and analogs' [patent_app_type] => 1 [patent_app_number] => 7/958903 [patent_app_country] => US [patent_app_date] => 1992-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 23 [patent_no_of_words] => 21224 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652214.pdf [firstpage_image] =>[orig_patent_app_number] => 958903 [rel_patent_id] =>[rel_patent_doc_number] =>)